Evaro closes $25 million Series A funding

Led by AlbionVC, the funds will be used to help the Norfolk-based NHS-licensed digital healthcare platform scale its healthcare-as-a-service model. 

Norfolk-based NHS-licensed digital healthcare platform Evaro has closed $25 million (£18.1 million) Series A funding to help scale its healthcare-as-a-service model.

The round was led by AlbionVC, the technology investment arm of Albion Capital Group, with participation from Simplyhealth Ventures, Exceptional Ventures, Cornerstone VC, and BBI. 

Founded in 2018 by emergency physician Thuria Wenbar and pharmacist researcher Oskar Wenbar, Evaro serves three distinct markets: consumer brands wanting to generate new revenue; healthcare providers expanding digital capacity for common conditions; and employers deploying health benefits.

The platform already partners with period-tracking app Clue and sexual wellness retailer Lovehoney, embedding prescription services directly into their customer experiences.

The funding will allow expansion across treatment areas (women’s health, men’s health, and longevity medicine), clinical capabilities such as diagnostics and aftercare, and platform development.

Evaro helps alleviate the burden on the NHS by providing complete regulated healthcare infrastructure – asynchronous consultations allowing speed and discretion of care, remote diagnostics, prescribing, dispensing, and aftercare – that can be embedded into any platform people spend time on within days. 

For partners, the model creates a new revenue stream with minimal implementation burden. Integrations can be completed in as little as two weeks while deepening customer relationships through an expanded health offering. 

Evaro holds comprehensive regulatory credentials. It has been licensed by the Care Quality Commission and General Pharmaceutical Council since 2018, and has seven active regulatory approvals and NHS integration, enabling GP record access for safer prescribing.

“What we’ve built is infrastructure that allows our partners – brands people already trust – to deliver safe and regulated healthcare for common conditions without having to build a thing,” said chief executive Thuria Wenbar. 

“We’re making healthcare as accessible as online banking, and this funding lets us prove that model works at scale,” she added.